Contact
searchSearch
HMP Global
Videos

Myth Buster: If Treatment is Working, Patients Can Stop it Immediately

Justin M. Ko, MD, MBA
Riya Gandhi, MA
07/08/2026

Can patients stop alopecia areata treatment after hair regrowth? Dr Justin Ko explains relapse risk, maintenance therapy, and long-term management.

© 2026 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Dermatology Learning Network or HMP Global, their employees, and affiliates.

Related Content

Asempa
Videos
Myth Buster: Shared Decision-Making is Easy in Alopecia Areata
08/06/2026
Oyetewa Boluwatito Asempa, MD, FAAD; Riya Gandhi, MA
Shared decision-making in alopecia areata is often more complex than it appears. Dr Oyetewa Asempa discusses aligning treatment goals, managing expectations, and improving patient-clinician communication.
Shared decision-making in alopecia areata is often more complex than it appears. Dr Oyetewa Asempa discusses aligning treatment goals, managing expectations, and improving patient-clinician communication.
Shared decision-making in...
08/06/2026
The Dermatologist
Draelos
Videos
Myth Buster: Hair Regrowth is the Only Outcome That Matters
08/06/2026
Zoe Diana Draelos, MD; Riya Gandhi, MA
Hair regrowth is only one measure of success in alopecia areata. Dr Zoe Draelos highlights patient-centered outcomes, quality of life, emotional well-being, and long-term disease control.
Hair regrowth is only one measure of success in alopecia areata. Dr Zoe Draelos highlights patient-centered outcomes, quality of life, emotional well-being, and long-term disease control.
Hair regrowth is only one...
08/06/2026
The Dermatologist
Draelos
Videos
Myth Buster: Children are More Resilient to Alopecia Areata Than Adults
08/06/2026
Zoe Diana Draelos, MD; Riya Gandhi, MA
Pediatric alopecia areata can have profound emotional and social consequences. Dr Zoe Draelos examines the unique psychological challenges facing children and adolescents with the disease.
Pediatric alopecia areata can have profound emotional and social consequences. Dr Zoe Draelos examines the unique psychological challenges facing children and adolescents with the disease.
Pediatric alopecia areata can...
08/06/2026
The Dermatologist
Draelos
Videos
Myth Buster: Patients Will Adjust to Alopecia Areata Over Time
08/06/2026
Zoe Diana Draelos, MD; Riya Gandhi, MA
Adapting to alopecia areata isn't always a linear process. Dr Zoe Draelos discusses the lasting emotional impact of the disease and why ongoing psychosocial support remains essential.
Adapting to alopecia areata isn't always a linear process. Dr Zoe Draelos discusses the lasting emotional impact of the disease and why ongoing psychosocial support remains essential.
Adapting to alopecia areata...
08/06/2026
The Dermatologist

Popular Articles

Conference Preview
“One for All:” DNA Annual Convention Preview
09/06/2024
Olanda Hathaway, MSN, FNP-BC, DCNP
The Dermatology Nurses’ Association hosts its 43rd yearly meeting in Orlando, FL, March 5–8, 2025, offering in-person educational and networking opportunities to promote patient care excellence.
The Dermatology Nurses’ Association hosts its 43rd yearly meeting in Orlando, FL, March 5–8, 2025, offering in-person educational and networking opportunities to promote patient care excellence.
The Dermatology Nurses’...
09/06/2024
The Dermatologist
acne
News
Topical Clindamycin: A Safe Choice for Acne Treatment Despite GI Concerns
10/31/2024
Riya Gandhi, MA
A recent review highlighted the safety of topical clindamycin, a popular antibiotic treatment for acne vulgaris.
A recent review highlighted the safety of topical clindamycin, a popular antibiotic treatment for acne vulgaris.
A recent review highlighted the...
10/31/2024
The Dermatologist
atopic dermatitis
FDA Alerts
Lebrikizumab FDA Approved for Moderate to Severe Atopic Dermatitis in Adults and Children
09/16/2024
Jessica Garlewicz
The US Food and Drug Administration has approved Eli Lilly’s EBGLYSS (lebrikizumab-lbkz), an IL-13 inhibitor, for the treatment of moderate to severe atopic dermatitis in adults and children.
The US Food and Drug Administration has approved Eli Lilly’s EBGLYSS (lebrikizumab-lbkz), an IL-13 inhibitor, for the treatment of moderate to severe atopic dermatitis in adults and children.
The US Food and Drug...
09/16/2024
The Dermatologist
Dr Adam Friedman
Podcasts
The Real Derm: Episode 5, Diving Deep Into the DermPath Pathway: A Candidate's Perspective
07/10/2025
Adam Friedman, MD
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to...
07/10/2025
The Dermatologist
Aesthetics Corner
The Future of Regenerative Medicine: Innovations to Watch
10/07/2024
Riya Gandhi, MA
Gain key insights on emerging technologies and their potential impact on patient care.
Gain key insights on emerging technologies and their potential impact on patient care.
Gain key insights on emerging...
10/07/2024
The Dermatologist
July/August 2026

Current Issue

August 2026
Volume 34
Issue 5
Current Issue
Issue Archive

Latest Quizzes and Trivia

AD
Quiz
Pediatric AD Quiz: Biologic Therapy Challenges in Children
08/10/2026
Riya Gandhi, MA
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of...
08/10/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: When to Escalate to Systemic Therapy
08/10/2026
Riya Gandhi, MA
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment...
08/10/2026
The Dermatologist
Quiz
Type 2 Endotypes and Therapeutic Strategy in Prurigo Nodularis
06/25/2026
Riya Gandhi, MA
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type...
06/25/2026
The Dermatologist
itch
Quiz
Fibrosis and Persistent Itch in Prurigo Nodularis
06/15/2026
Riya Gandhi, MA
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding...
06/15/2026
The Dermatologist
brain
Quiz
Neuroimmune Mechanisms and Cytokine Signaling in Prurigo Nodularis
06/05/2026
Riya Gandhi, MA
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in...
06/05/2026
The Dermatologist
Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist
Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use